Elizabeth Chesnut BA

With over 22 years of experience in pharmaceutical and CRO settings, Elizabeth brings a wealth of knowledge to Siolta’s clinical trial development and management activities. Elizabeth has lead and managed national and international clinical trials focused on a variety of therapeutic areas, including chronic obstructive pulmonary disorder, type II diabetes, and inflammatory bowel disease. Her successful tenure managing programs spanning Phase I through pivotal Phase III trials, as well as her knowledge of ICH Guidelines and GCP, make her well suited to oversee Siolta’s clinical development activities.